GL Ventures is the early-stage venture capital arm of Hillhouse Capital (Hillhouse Investment), spun off in 2020 as an independent fund. It invests primarily in early-stage startups across biomedicine and medical devices, software services and technology innovation, consumer internet, and emerging consumer brands.
They made 8 investments in the last 12 months. Average disclosed round size is $150.9M (across 57 rounds with reported amounts).
Portfolio
70
Fund Size
—
Top Stage
Series A
Last 12 Mo
8
Team
Tomohiro Kikuta
Partner
Michael Yi
Co-Chief Investment Officer
Adam Hornung
Co-Chief Operating Officer & General Counsel
Joe Gagnon
Co-Head of Real Assets - Rava Partners
Lei Zhang
Founder & Chairman
Siddhartha Hari
Co-Head of Private Credit - Elham Credit
Audrey Woon
Carl Ge
Cathy Liu
Charles Dirrig
Luke Li
Sandeep Chandak
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
 Maxvax | Series B | — | Sep 2026 |
 Galaxea | Series B | $290M | Apr 2026 |
| SSyneron Bio | Series B | $150M | Mar 2026 |
 Aridge | Unknown | $200M | Mar 2026 |
| DDify | Series A | $30M | Mar 2026 |
 Copla | Series A | $6.3M | Feb 2026 |
 Clipto | Seed | — | Jan 2026 |
 D-Robotics | Series B | $270M | Jan 2026 |
| Aridge | Series A | $200M | Jan 2026 |
 Xpeng Huitian | Series B | $200M | Jan 2026 |
| TTianJi | Series B | $147M | Jan 2026 |
| D-Robotics | Growth | $150M | Jan 2026 |
 Tars | Seed | $455M | Jan 2026 |
| D-Robotics | Series C | $400M | Jan 2026 |
| SSyneron Bio | Series A | — | Dec 2025 |
 Xense Robotics | Series A | — | Oct 2025 |
 Beatbot | Unknown | — | Jan 2025 |
 Dealism | Seed | $15M | Jan 2025 |
| CClipto AI | Seed | — | Jan 2025 |
| Xense Robotics | Series A | — | Jan 2025 |
 LTZ Therapeutics | Series A | $20M | Aug 2024 |
| CCyber Upgrade | Pre-Seed | — | Feb 2024 |
 Iaso Biotherapeutics | Series B | — | Jan 2023 |
 TENWAYS | Series A | — | Jan 2023 |
 ILLA | Seed | — | Nov 2022 |
Top Co-Investors
Last updated: 7 October 2026